Real-world Efficacy and Prognostic Factors of Lenvatinib Plus PD-1 Inhibitors in 378 Unresectable Hepatocellular Carcinoma Patients.
HEPATOLOGY INTERNATIONAL(2023)
Key words
Hepatocellular carcinoma,Un-resectable,Lenvatinib,PD-1 inhibitor,Pembrolizumab,Nivolumab,Adverse events,Hepatitis B virus
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined